--Hos$2mane (talk) 10:28, 25 June 2008 (UTC)Under Career, 4th paragraph, for hepatitis B virus (HBV), please cite the following reference:
R. K. Sood, V. S. Bhadti, A. I. Fattom, R. B. Naso, H. Chen, B. E. Korba, E. Kern, and R. S. Hosmane,* "Novel Ring-Expanded Nucleoside Analogs Exhibit Potent and Selective Inhibition of Hepatitis B Virus Replication in Cultured Human Hepatoblastoma Cells," Antiviral Res., 2002,53, 159-164.
In the same 4th paragraph, for hepatitis C (HCV) virus, please cite the following reference:
P. Zhang, N. Zhang, V. Buckwold, R. S. Hosmane,* “Chemical and biological effects of substitution of the 2-position of ring-expanded (“fat”) nucleosides containing the imidazo[4,5-e][1,3] diazepine-4,8-dione ring system: The role of electronic and steric factors on glycosidic bond stability and anti-HCV activity,” Bioorg. Med. Chem., 2007, 15, 4933-4945.
In the same 4th paragraph, for human immunodeficiency virus (HIV), please cite the following reference:
V. S. R. K. Yedavalli, N. Zhang, P. Zhang, H. Cai, M. F. Starost, R. S. Hosmane,* and K-T. Jeang,* ” Ring-Expanded (REN) Nucleoside Analogues Inhibit RNA Helicase and Intracellular HIV-1 Replication, ” J. Med. Chem. 2008, 51,
In the same 4th paragraph, for the West Nile virus, please cite the following reference:
N. Zhang, H.-M. Chen, V. Koch, H. Schmitz, C.-L. Liao, A. I. Fattom, R. B. Naso, K. Kalicharran, P. Borowski, and R. S. Hosmane,* "Potent inhibition of NTPase/helicase of the West Nile Virus by Ring-Expanded Nucleoside (REN) Analogues," J. Med. Chem. 2003, 46, 4776 - 4789.
For the Japanese Encephalitis virus (JEV), please cite the following reference:
N. Zhang, H.-M. Chen, V. Koch, H. Schmitz, C.-L. Liao, M. Bretner, V. S. Bhadti, A. I. Fattom, R. B. Naso, R. S. Hosmane,* and P. Borowski,* "Ring-Expanded Nucleoside and Nucleotide (REN) Analogues Exhibit Potent In Vitro Activity Against Flaviviridae NTPases/Helicases, including Those of the West Nile Virus (WNV), Hepatitis C Virus (HCV), and Japanese Encephalitis Virus (JEV)," J. Med. Chem. 2003, 46, 4149-4164.
For the measles virus, please cite the following reference:
N. Zhang, H. -M. Chen, R. Sood, K. Kalicharran, A. I. Fattom, R. B. Naso, D. L. Barnard, R. W. Sidwell, and R. S. Hosmane,* "In Vitro Inhibition of Measles Virus Replication by Novel Ring-Expanded (“Fat”) Nucleoside Analogues Containing the Imidazo[4,5-e][1,3]diazepine Ring System, Bioorg. Med. Chem. Lett. 2002, 12, 3391-3394.
For all the remaining viruses listed in the same 4th paragraph (Rhino, VZV, EB, RSV, Influenza, Herpes) and cancers (prpstate, lung, breast, colon, and leukemia), please cite the following two references:
(a) R. S. Hosmane, "Ring-Expanded ("Fat") Nucleosides as Broad-Spectrum Anticancer and Antiviral Agents," in "Current Topics in Medicinal Chemistry: Recent Developments in Antiviral Nucleosides, Nucleotides, and Oligonucleotides," Hosmane, R. S., Ed., Bentham Science Publishers, 2002, Vol. 2, pp. 1093-1109.
(b) R. S. Hosmane, “Antiviral Agents,” in Kirk-Othmer Encyclopedia of Chemical Technology (5th Edition), John Wiley & Sons, New York, 2004, Vol. 3, pp 135-182.
In the same 4th paragraph, the first sentence, where it says blood substitutes based on hemoglobins, please cite the following four references:
(a) S. P. Peri, V. S. Bhadti, R. S. Hosmane,* and V. W. Macdonald, "Bis[2-(4-carboxyphenoxy)carbonyl- ethyl)phosphinic Acid (BCCEP): A New Reagent for Hemoglobin Modification," Artif. Cells Blood Subst. Immobil. Biotech. 1997, 25, 511-520.
(b) R. S. Hosmane,* S. P. Peri, V. S. Bhadti, and V. W. Macdonald, "Bis[2-(4-carboxyphenoxy)carbonyl- ethyl]phosphinic Acid (BCCEP): A Novel Affinity Reagent for the b-Cleft Modification of Human Hemoglobin," Bioorg. Med. Chem.1998, 6, 767-783.
(c) S. P. Peri, V. S. Bhadti, R. Liang, R. S. Hosmane,* and V. W. Macdonald, "Affinity Reagents for Cross-Linking Hemoglobin: Bis(phenoxycarbonylethyl) phosphinic Acid (BPCEP) and Bis(3-nitrophenoxycarbonylethyl)phosphinic Acid (BNCEP)," Hemoglobin1999, 23, 1-20.
(d) T. A. Roach, V. W. Macdonald, and R. S. Hosmane, “A Novel Site-Directed Affinity Reagent for Cross-Linking Human Hemoglobin: Bis[2-(4-phosphonooxy phenoxy)carbonylethyl]phosphinic Acid (BPPCEP)” J. Med. Chem., 2004, 47, 5847-5859.